Does PDA need medication?

Managing PDA in Newborns: When Medication Helps

Patent Ductus Arteriosus (PDA) is a common condition in premature infants, where a blood vessel in the heart—the ductus arteriosus—fails to close after birth. This persistent opening allows oxygen-rich and oxygen-poor blood to mix, which can strain the heart and lead to complications like fluid overload and heart failure.

Medication often plays a key role in treatment. In many cases, doctors first try to manage symptoms by limiting fluid intake and prescribing diuretics to reduce the extra fluid burden on the baby’s heart. But to actually close the ductus, medication is frequently used. A common approach involves giving a non-steroidal anti-inflammatory drug (NSAID), such as ibuprofen, intravenously. This medicine helps mimic the natural drop in prostaglandins—hormone-like substances that keep the ductus open in the womb—encouraging the vessel to close on its own.

For many preterm babies, this medical treatment is effective, especially when started early. Success rates are generally higher in the first days of life, before the vessel becomes less responsive. When medication doesn’t work or isn’t suitable—often due to other health concerns—doctors may consider minimally invasive procedures or surgery to close the PDA.

Timing and careful monitoring are crucial. Not every PDA requires intervention—some close spontaneously—but for those that don’t, prompt and tailored treatment improves outcomes. Each baby’s case is unique, and decisions are always made with their overall health in mind. With advances in neonatal care, most infants with PDA go on to thrive, thanks to timely medical support and close observation in the NICU.